Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery
Sponsor: American Heart Association
This PHASE1/PHASE2 trial investigates Atrial Fibrillation and is currently completed. American Heart Association leads this study, which shows 12 recorded versions since 2015 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE1_PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE1_PHASE2
▶ Show 7 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Jul 2017 — Dec 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Jul 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American Heart Association
- Foundation for Anesthesia Education and Research
- Joseph Mathew, M.D.
For direct contact, visit the study record on ClinicalTrials.gov .